Literature DB >> 7989612

Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.

B Zöller1, P J Svensson, X He, B Dahlbäck.   

Abstract

Resistance to activated protein C (APC) is the most prevalent inherited cause of venous thrombosis. The APC resistance phenotype is associated with a single point mutation in the factor V gene, changing Arg506 in the APC cleavage site to a Gln. We have investigated 50 Swedish families with inherited APC resistance for this mutation and found it to be present in 47 of them. Perfect cosegregation between a low APC ratio and the presence of mutation was seen in 40 families. In seven families, the co-segregation was not perfect as 12 out of 57 APC-resistant family members were found to lack the mutation. Moreover, in three families with APC resistance, the factor V gene mutation was not found, suggesting another still unidentified cause of inherited APC resistance. Of 308 investigated families members, 146 were normal, 144 heterozygotes, and 18 homozygotes for the factor V gene mutation and there were significant differences in thrombosis-free survival curves between these groups. By age 33 yr, 8% of normals, 20% of heterozygotes, and 40% of homozygotes had had manifestation of venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989612      PMCID: PMC330087          DOI: 10.1172/JCI117623

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay.

Authors:  E M Faioni; F Franchi; D Asti; E Sacchi; F Bernardi; P M Mannucci
Journal:  Thromb Haemost       Date:  1993-12-20       Impact factor: 5.249

2.  Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C.

Authors:  B Lindblad; P J Svensson; B Dahlbäck
Journal:  Lancet       Date:  1994-04-09       Impact factor: 79.321

3.  Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.

Authors:  B Dahlbäck; B Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

4.  Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa.

Authors:  L Shen; B Dahlbäck
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

5.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

6.  Resistance to activated protein C as a basis for venous thrombosis.

Authors:  P J Svensson; B Dahlbäck
Journal:  N Engl J Med       Date:  1994-02-24       Impact factor: 91.245

7.  Anticoagulant protein C pathway defective in majority of thrombophilic patients.

Authors:  J H Griffin; B Evatt; C Wideman; J A Fernández
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

8.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

9.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

10.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more
  45 in total

Review 1.  Thrombophilia: a genetic predisposition to thrombosis.

Authors:  R A Sacher
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

2.  Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.

Authors:  C Hvarfner; A Hillarp; J Larsson
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

Review 3.  Inherited thrombophilia: memorandum from a joint WHO/International Society on Thrombosis and Haemostasis meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

4.  Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis.

Authors:  E Wilder-Smith; I Kothbauer-Margreiter; B Lämmle; M Sturzenegger; C Ozdoba; S P Hauser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

5.  An assessment of the comparative utility of functional and molecular level analyses in the investigation of patients with thrombophilia.

Authors:  B Clark; C Caine; E N McSweeney; B A McVerry; H C Gooi
Journal:  Clin Mol Pathol       Date:  1996-08

6.  Henoch-Schonlein purpura: polymorphisms in thrombophilia genes.

Authors:  Efrat Dagan; Riva Brik; Yiphtah Broza; Ruth Gershoni-Baruch
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

7.  Impact of smoking during pregnancy on functional coagulation testing.

Authors:  Donna Dizon-Townson; Connie Miller; Valerija Momirova; Baha Sibai; Catherine Y Spong; George Wendel; Katharine Wenstrom; Philip Samuels; Steve Caritis; Yoram Sorokin; Menachem Miodovnik; Mary J O'Sullivan; Deborah Conway; Ronald J Wapner; Steven G Gabbe
Journal:  Am J Perinatol       Date:  2011-08-04       Impact factor: 1.862

8.  Detection of a common mutation in factor V gene responsible for resistance to activate protein C causing predisposition to thrombosis.

Authors:  A Ferreira-Gonzalez; L M Fisher; C M Lehman; M H Langley; D H Lofland; Q Xia; N X Nguyen; D Modesto; J B Willoughby; D S Wilkinson; C T Garrett
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

9.  Activated protein C and retinal vein occlusion.

Authors:  B J Hunt
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

10.  Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease.

Authors:  O D Pedersen; J Gram; J Jespersen
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.